Ubs Group Ag Vericel Corp Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Vericel Corp stock. As of the latest transaction made, Ubs Group Ag holds 117,719 shares of VCEL stock, worth $5.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117,719
Previous 68,563
71.69%
Holding current value
$5.65 Million
Previous $2.9 Million
123.17%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding VCEL
# of Institutions
292Shares Held
49.4MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$386 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$167 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$155 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$115 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$107 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.26B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...